5-ARIs Linked With Depression, But Not Suicide Risk
This Swedish population-based study has the largest sample size to date exploring these associations.
This Swedish population-based study has the largest sample size to date exploring these associations.
The update reflects advances in hepatitis C management, such as antiviral therapy, increased use of hepatitis C kidney grafts, and treatment of glomerular diseases associated with the virus.
Blocking the endothelin pathway could represent a new mode of action to lower blood pressure in resistant hypertension, according to investigators.
Stopping renin-angiotensin-aldosterone inhibitors after hyperkalemia may offset their potential clinical benefits, according to investigators.
Findings were consistent for patients aged 80 years or older and patients with chronic kidney disease, who are often underrepresented in clinical trials.
Treatment with an SGLT2 inhibitor may help patients with CKD or type 2 diabetes better preserve their kidney function.
Finerenone, a mineralocorticoid receptor antagonist, may exert anti-inflammatory and anti-fibrotic effects, according to investigators.
Vaccination decreased the risk for COVID-related hospitalization and death, according to a retrospective study.
Nirmatrelvir/ritonavir is not current recommended for patients with CKD stage 4 or 5, but low-dose regimens could avoid adverse events, according to the authors of a recent editorial.
A round up of studies suggests it is difficult to increase serum total 25-hydroxyvitamin D levels enough to effectively lower elevated parathyroid hormone (PTH) levels in overweight patients with chronic kidney disease.